PROTHYM Phase II non-randomized study on proton radiotherapy of thymic malignancies Version 2.2 21 June 2017 Phase II non-randomized study on Proton Radiotherapy Of Thymic Malignancies Version 2.2 Supported by SLUSG: Swedish Lung cancer Study Group Investigator signature: Date: __________________________________________________________ Principal investigator Jan Nyman, MD, PhD Department of Oncology Sahlgrenska University Hospital 2 Gothenburg
[email protected] Study Coordinating center: Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden Study Participants/ Co investigator Dr Andreas Hallqvist, MD Dr Hedvig Björkestrand, MD Department of Oncology Department of Oncology Sahlgrenska University Hospital University Hospital Karolinska Gothenburg Stockholm
[email protected] [email protected] Dr Signe Friesland, MD, PhD Dr Annica Ravn-Fischer, MD, PhD Department of Oncology Department of Cardiology University Hospital Karolinska Sahlgrenska University Hospital Stockholm Gothenburg
[email protected] [email protected] Dr Kristina Nilsson, MD, PhD Anna Bäck, Med Phys, PhD Department of Oncology Department of Radiotherapy University Hospital Uppsala Sahlgrenska University Hospital Uppsala Gothenburg kristina.nilsson@akademiska .se
[email protected] Dr Per Bergström, MD Dr Jens Engleson, MD Department of Oncology Department of Radiotherapy University Hospital Norrland Skåne University Hospital Umeå Lund per.bergströ
[email protected] [email protected] Dr Jan